Form 4: Merit Medical Systems Insider Sells Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Raul Parra Jr., CFO and Treasurer of Merit Medical Systems Inc., reported a transaction involving the sale of common stock.

Summary

  • Raul Parra Jr., the Chief Financial Officer and Treasurer of Merit Medical Systems Inc. (MMSI), has reported a transaction.
  • On May 6, 2026, Mr. Parra sold 1,500 shares of common stock at a price of $61.01 per share.
  • Following this transaction, Mr. Parra beneficially owns 58,843 shares of common stock.
  • Additionally, the filing notes that Mr. Parra has 2,699 shares held indirectly through a 401(k) plan.
  • The filing also details outstanding non-qualified stock options held by Mr. Parra, with exercise prices of $65.03 and $70.58, which become exercisable in installments starting in 2023 and 2024, respectively.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports a standard insider stock sale without providing additional context on the company's performance or future prospects.

Negatives

  • Insider selling of company stock can sometimes be perceived negatively by the market, although the reasons for such sales are not always indicative of a lack of confidence in the company's future.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on a past transaction and existing option grants.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While this specific filing details a sale by a key executive, it does not provide strategic insights into Merit Medical Systems' operations or market position relative to industry peers.

Stakeholder Impact

  • Shareholders: The sale of shares by an executive may lead to questions about the executive's confidence in the company, although the reasons for the sale are not detailed in this filing.

Key Dates

DateDescription
02/28/2023First installment of exercisability for non-qualified stock options with an exercise price of $65.03 begins.
02/28/2024First installment of exercisability for non-qualified stock options with an exercise price of $70.58 begins.
05/05/2026Date as of which plan holdings (401(k)) are reported.
05/06/2026Date of the reported stock sale transaction.
05/07/2026Date the Form 4 filing was signed by the attorney-in-fact.

Keywords

Form 4, Insider Transaction, Stock Sale, Merit Medical Systems, MMSI, Raul Parra Jr., CFO, Beneficial Ownership, Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.